Strand Displacement Amplification Market Size & Share, by Product Type (Instruments, Reagents & Consumables); Application (Tuberculosis, Hepatitis, Malaria, Influenza, Cancer); End-user (Hospitals, Diagnostics Laboratories) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5259
  • Published Date: Sep 25, 2023
  • Report Format: PDF, PPT

Companies Dominating the Strand Displacement Amplification Landscape

    • Lucira Health Inc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Sherlock Biosciences
    • Lucigen Corporation
    • Bio-Rad Laboratories Inc
    • G-Biosciences
    • New England Bio-Labs
    • Geno Technologies Inc
    • Nippon Genetics Co, Ltd.
    • Proteon Pharmaceuticals
    • Hopan Fine Chemicals

Browse Key Market Insights with Data Illustration:


In The News

  • To achieve its objective of making diagnostics simple to use, inexpensive, disposable, and environmentally friendly, Sherlock Biosciences purchased Sense Biodetection in February 2023. Products for SDA-based diagnostics are offered by Sense Biodetection.
  • The FDA received an emergency use authorization request from Lucira Health, Inc. in January 2023 for the OTC use of their straightforward, at-home molecular COVID-19 and flu test, which makes use of SDA technology.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5259
  • Published Date: Sep 25, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of infectious diseases and increasing awareness about the benefits of strand displacement amplification are some of the major factors anticipated to drive the growth of the strand displacement amplification market.

The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2024 – 2036.

The major players in the market are Sherlock Biosciences, Lucigen Corporation, Bio-Rad Laboratories Inc., G-Biosciences, New England Bio-Labs, Geno Technologies Inc., and others.

The diagnostic laboratories segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying